Michael Mano
General Counsel
Karyopharm Therapeutics Inc. (KPTI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Mano
Michael Mano is recorded as General Counsel at Karyopharm Therapeutics Inc. (KPTI). The proxy statement of Karyopharm Therapeutics Inc. reports total compensation of $2,060,407 for Michael Mano in fiscal 2022, including a base salary of $427,333.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Karyopharm Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Richard Paulson CEO, Board Member
- Senior Clinical CEO
- Kristin Abate Chief Accounting Officer
- Barry E. Greene Board Member
- Chen Schor Board Member
- Christy J Oliger Board Member
- Christy J. Oliger Board Member
- Deepika R. Pakianathan Board Member
- Garen G. Bohlin Board Member
- Mansoor Raza Mirza M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Karyopharm Therapeutics Inc. (KPTI) | — | $427,333 | $2,060,407 |
Recent activity
No call appearances or filed executive changes recorded yet.